在CNP类似物赛道，Ascendis的TransCon-CNP率先实现了剂型升级。与Vosoritide不一样的设计是TransCon-CNP被一层保护分子包裹，降低了体内清除影响，延长作用时间，实现每周一次给药。非头对头临床数据显示，TransCon-CNP每年2.29厘米的增高表现也优于Vosoritide。
Digest: sha256:5638b6581830be13c9ae418c5d1587f36c7f99b3860326fa7b163bef70236438，更多细节参见爱思助手下载最新版本
"code": "invalid_amount",，这一点在heLLoword翻译官方下载中也有详细论述
I put a lot of time into writing this, and I hope that you enjoy reading
In her survey, 22% of mothers and 20% of childless women picked such small gestures as one of the top two things that made them feel valued – more than big nights out or expensive presents.